Sequencing Therapies in Patients With Rectal Cancer and a Single Lung Nodule
Timil Patel, MD, discusses how to sequence therapies in a patient with rectal cancer with a single lung nodule.
Timil Patel, MD, clinical fellow in Hematology/Oncology, Yale School of Medicine, discusses how to sequence therapies in a patient with rectal cancer with a single lung nodule.
Sequencing therapies in this patient population depends on how effective the first line of therapy is, says Patel. Generally, the first line of therapy will be a systemic therapy. Later on, Patel says patients will be restaged to make sure there is no further progression, and that the primary and metastatic sites have regressed in the patient.
The next steps for this patient include a discussion with a multidisciplinary board or tumor board. Most centers will agree that in rectal cancer with a single site that has a good response to chemotherapy, the next line of therapy would be to treat the primary cancer with chemoradiotherapy, says Patel. The goal of this treatment is to cure the patient, he adds.
Durvalumab Plus Chemo Continues to Improve Survival in Biliary Tract Cancer
April 16th 2024Results from a 3-year follow-up of the TOPAZ-1 trial showed that treatment with durvalumab plus chemotherapy in advanced biliary tract cancer continued to improve overall survival vs chemotherapy alone.
Read More
KEYNOTE-859 Outcomes Influence NCCN Guidelines on Pembrolizumab in Upper GI Cancer
April 10th 2024During a Case-Based Roundtable® event, David Zhen, MD, discussed how treatment of upper gastrointestinal cancer with pembrolizumab and chemotherapy is impacted by PD-L1 composite positive score, in the second article of a 2-part series.
Read More
